Cat.#: ACPP-1357
| Despition | P2Y12 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1337 | Neurochondrin Blocking Peptide (AC1337) | 250 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
| ACPP-1780 | Human DYRK1A Protein (AC1780) | 5 µg | inquiry |
| ACPP-1326 | Galectin 3 Blocking Peptide (AC1326) | 250 µg | inquiry |
| ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
| ACPP-1077 | CaMKII gamma Blocking Peptide (AC1077) | 250 µg | inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1693 | Human CDK1 Protein (AC1693) | 5 µg | inquiry |
| ACPP-1081 | Human NRN1 Protein (AC1081) | 5 µg | inquiry |
| ACPP-1055 | Recombinant Human TIMP1 Protein (Fc Tag) (AC1055) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.